European study aims to unlock secrets of CMV in transplant patients
NCT ID NCT05701228
First seen Jan 19, 2026 · Last updated May 23, 2026 · Updated 20 times
Summary
This study is collecting medical information and biological samples from 552 organ transplant recipients across Europe. The goal is to better understand how the body interacts with the cytomegalovirus (CMV) after transplantation. By analyzing this data, researchers hope to reduce the burden of CMV disease and improve patient well-being.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hopitel Pellegrin
Bordeaux, 33076, France
-
Hôpital Edouard Hériot
Lyon, 69003, France
-
Hôpital Foch
Suresnes, 92150, France
-
Hôpital LA PITIE SALPETRIERE
Paris, 75013, France
-
Hôpital Necker
Paris, 75015, France
-
Hôpital Paul Brousse
Villejuif, 94804, France
-
Hôpital Rangueil
Toulouse, 31059, France
Conditions
Explore the condition pages connected to this study.